Symfi Lo™ (efavirenz/lamivudine/tenofovir disoproxil fumarate) – New drug approval
February 7, 2018 - The FDA announced the approval of Mylan’s Symfi Lo (efavirenz [EFV]/lamivudine [3TC]/tenofovir disoproxil fumarate [TDF]) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients weighing at least 35 k.
Top